Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | SI | P14410 | 2/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | DGKA | P23743 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10783705 | 0.89 | CES2 (0.39) | MGAMGAASIMGAM2THRB | |
| SCHEMBL1791414 | 0.84 | ADRA2A (0.43) | THRBALDH1A1TSHRCES2TP53 | |
| SCHEMBL16352656 | 0.84 | MGAM (0.38) | MGAMGAASIMGAM2THRB | |
| SCHEMBL25952323 | 0.84 | GAA (0.48) | MGAMGAASIMGAM2THRB | |
| SCHEMBL11408466 | 0.83 | GAA (0.52) | MGAMGAASIMGAM2THRB | |
| SCHEMBL8380310 | 0.83 | GAA (0.52) | MGAMGAASIMGAM2THRB | |
| SCHEMBL2704967 | 0.83 | GAA (0.52) | MGAMGAASIMGAM2THRB | |
| SCHEMBL20335287 | 0.82 | THRB (0.46) | GAATHRBALDH1A1TSHRCES2 | |
| SCHEMBL13660340 | 0.82 | MGAM (0.41) | MGAMGAASIMGAM2THRB | |
| SCHEMBL14153013 | 0.82 | MGAM (0.36) | MGAMGAASIMGAM2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1088865-B1 | Ink composition and ink jet recording method using the same | SEIKO EPSON CORP (JP) | 2005-05-11 | — | — | EP | claimed |
| US-6538047-B1 | Encapsulated in polymerized surfactant and ligand; dispersion and ejection stability | SEIKO EPSON CORPORATION (JP) | 2003-03-25 | — | — | US | claimed |
| EP-1088865-A1 | Ink composition and ink jet recording method using the same | SEIKO EPSON CORPORATION (JP) | 2001-04-04 | — | — | EP | claimed |
| JP-11335222-A | — | — | None | — | — | JP | disclosed |
| CN-117412998-B | Compositions comprising cyclic imide-containing monomers and organoborane complexes, and related articles and methods | 3M创新有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-117412998-A | Compositions comprising cyclic imide-containing monomers and organoborane complexes, and related articles and methods | 3M创新有限公司 | 2024-01-16 | — | — | CN | disclosed |
| EP-1454921-B1 | RADICAL POLYMERIZATION CATALYSTS AND ADHESIVE KIT FOR DENTAL USE | TOKUYAMA CORP (JP) | 2021-07-28 | — | — | EP | disclosed |
| EP-1749859-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2019-09-11 | — | — | EP | disclosed |
| EP-1746134-B1 | CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS | KANEKA CORP (JP) | 2019-09-04 | — | — | EP | disclosed |
| EP-1746135-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-10251392-B2 | Antimicrobial devices and compositions | AVENT, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| US-5604070-A | Liquid toners with hydrocarbon solvents | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-02-18 | — | — | US | disclosed |
| US-5599886-A | Liquid toners with hydrocarbon solvents | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-02-04 | — | — | US | disclosed |
| EP-0727450-A1 | Liquid toners with hydrocarbon solvents | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-08-21 | — | — | EP | disclosed |
| US-5521271-A | Liquid toners with hydrocarbon solvents | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0706095-A1 | Liquid toners with hydrocarbon solvents | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-04-10 | — | — | EP | disclosed |
| EP-0022545-B1 | VINYL POLYMER WITH ACETYL ACETOXY GROUPS, PROCESS FOR ITS PREPARATION AND DISPERSION OBTAINED THEREFROM | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-06-13 | — | — | EP | disclosed |
| EP-0022978-B1 | ACETYLACETOXYALKYL ALLYL ETHERS, THEIR PREPARATION AND UTILIZATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-04-28 | — | — | EP | disclosed |
| EP-0022978-A1 | Acetylacetoxyalkyl allyl ethers, their preparation and utilization | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-01-28 | — | — | EP | disclosed |
| EP-0022545-A1 | Vinyl polymer with acetyl acetoxy groups, process for its preparation and dispersion obtained therefrom | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10251392-B2 | Antimicrobial devices and compositions | AAAS, AOC1, COL14A1 | MGAM 198/4885GAA 1128/4885SI 474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.